Loading...

TATVA Tatva Chintan Pharma Chem Ltd Other Situations Announcement

Ttv

TTV

Tatva Chintan Pharma Chem Ltd

(TATVA)

2026 Announcement

Earnings call transcript

Regulatory Compliance

Newspaper Publication

Earnings Call Recording

Q4FY26 & FY26 Presentation

Auditor appointments

Final dividend declaration

Board decisions and disclos...

Audited results

Earnings Call Intimation

Board Meeting Intimation

LC status confirmation

Regulatory disclosure

Compliance Certificate unde...

Trading Window Closure

Analyst / Institutional Meet

Gas supply disruption

Investor Meeting

Analyst / Investor Meeting ...

Inter-se transfer within pr...

Inter-se transfer under Reg...

Share Purchase Agreement

Analyst / Investor Meeting

Regulation 10(6) disclosure

SEBI SAST Disclosure

Promoter Acquisition

Regulatory Compliance

Promoter share transfer

Earnings Call Transcript

Newspaper publication of re...

Earnings call recording

Investor Presentation

Unaudited Financial Results

Quarterly results

Earnings Call Schedule

Regulatory Compliance

Trading Window Closure

Analyst / Institutional Inv...

Analyst / Institutional Mee...

One-on-One Meeting

Investor Meeting Scheduled

Investor Meeting Notice

Investor Meeting

Investor Meeting

Investor Meeting

Earnings Call Summary

Newspaper Publication

Earnings Call Recording

Investor Presentation

Management Authorization

Management Change

Board Meeting Outcome

Financial Results

Price Movement Clarified

Earnings Call Scheduled

Board Meeting Notice

Compliance Certificate

Investor Meeting

Investor Meeting

Investor Meeting

Annual Meeting Notice

100 Days Campaign

AGM Announcement

Investor Meeting Scheduled

Dividend Announcement

Investor Meeting Scheduled

Earnings Call Transcript

Financial Results Release

Earnings Call Recording

Investor Presentation

CFO Resignation

Directorate Changes

Earnings Call Scheduled

Compliance Certificate

Credit Rating Downgrade

Price Movement Clarification

Volume Increase Clarification

Annual Compliance Report

Earnings Call Transcript

Earnings Call Recording

Investor Presentation

Export Order Received

Financial Results News

Auditor Appointments

Earnings Call Rescheduled

Earnings Call Scheduled

Contact Details Update

Compliance Certificate

Investor Meeting

Investor Meeting Scheduled

Earnings Call Transcript

Financial Results Published

Earnings Call Recording

Investor Presentation

Earnings Call Scheduled

Compliance Certificate

Registrar Name Change

Investor Meeting Announced

Credit Rating Change

Earnings Update

Financial Results Published

Earnings Call Recording

Financial Results Update

Earnings Call Scheduled

Closure Revoked

Compliance Certificate

Share Volume Spike

Investor Meeting Scheduled

Regulatory Order

Investor Meeting Scheduled

AGM Announcement

AGM Announcement

AGM Announcement

Dividend Taxation Update

Investor Meeting Schedule

Earnings Call Transcript

Financial Results Publication

Earnings Call Recording

Investor Presentation

Earnings Call Schedule

Compliance Certificate

Investor Meeting Intimation

Investor Meeting

Compliance Report Submission

Earnings Call Transcript

Financial Results Published

Earnings Call Recording

Monitoring Agency Report

IPO Fund Utilization

Investor Presentation

Environmental Clearance

Earnings Call Schedule

Compliance Certificate Subm...

Certificate Submission

Compliance Certificate Subm...

Investor Meeting

Investor Meeting

Investor Meeting Intimation

Investor Meetings

Investor Meeting

Investor Meeting Schedule

Earnings Call Transcript

Monitoring Agency Report

Monitoring Agency Report Su...

Deviation in Fund Utilization

Utilization of IPO Funds

Financial Results Published

Earnings Call Recording

Investor Presentation

Earnings Call Scheduled

Compliance Certificate Subm...

Investor Meeting

Maintenance Shutdown

Report Submission

Earnings Call Transcript

Submission of Monitoring Ag...

Statement of Deviation/Vari...

Statement of Deviation

Newspaper Publication

Earnings Call Recording

Investor Presentation

Earnings Call Scheduled

Compliance Certificate Subm...

Credit Rating Reaffirmed

Insider Trading Report

Equity shares sale

Equity Shares Sold

Equity Share Sale

Equity Shares Sold

Equity Sale for Public Shar...

Qualified Institutional Pla...

Fund Raising Committee Meeting

Fund Raising Committee

Investor Meetings

Dividend Taxation

Financial Statements

Secondary Offerings

Investor Meetings

Financial Statements

Earnings Guidance

Financial Statements

Investor Meetings

New Product Launches

Investor Meetings

One-on-One Virtual meeting

Analyst/Investor Meet

Financial Updates

Monitoring Agency Report Su...

Rights Offerings

Publication of Financial Re...

Earnings Call Recording

Disclosure of Related Party...

Financial Statements

Financial Statement Release

External Links:

Data:

Tatva Chintan Pharma Chem confirms non-LC status, submits SEBI initial disclosure; outstanding borrowings ₹6.04 cr; CRISIL ratings BBB+/Stable and A2; no shortfall or fine anticipated.

AI Assistant

Tatva Chintan Pharma Chem Ltd

2026

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.